![](http://www.biohealthcapital.com/wp-content/uploads/2018/01/personal-genome-diagnostics-pgd-logo.png)
Personal Genome Diagnostics, a Baltimore-based cancer diagnostics company, has raised $75 million to expand access to genomic testing for cancer patients.
Personal Genome Diagnostics, a Baltimore-based cancer diagnostics company, has raised $75 million to expand access to genomic testing for cancer patients.